BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33951631)

  • 41. Diagnostic precision of component-resolved vs. extract-based in vitro diagnosis of hymenoptera venom allergy: effects on clinical management.
    Seyfarth F; Miguel D; Schliemann S; Hipler UC
    J Dtsch Dermatol Ges; 2017 May; 15(5):507-515. PubMed ID: 28485877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Insect venom allergy in childhood].
    Leupold W; Sander H
    Allerg Immunol (Leipz); 1991; 37(1):31-5. PubMed ID: 2063728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Honeybee and wasp venom allergy: Sensitization and immunotherapy.
    Adib-Tezer H; Bayerl C
    J Dtsch Dermatol Ges; 2018 Oct; 16(10):1228-1247. PubMed ID: 30300499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practice of venom immunotherapy in the United Kingdom: a national audit and review of literature.
    Diwakar L; Noorani S; Huissoon AP; Frew AJ; Krishna MT
    Clin Exp Allergy; 2008 Oct; 38(10):1651-8. PubMed ID: 18727621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insect allergy. Predictive value of diagnostic tests: a three-year follow-up study.
    Mosbech H; Christensen J; Dirksen A; Søborg M
    Clin Allergy; 1986 Sep; 16(5):433-40. PubMed ID: 3779939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IgE antibodies to Hymenoptera venoms in the serum are common in the general population and are related to indications of atopy.
    Schäfer T; Przybilla B
    Allergy; 1996 Jun; 51(6):372-7. PubMed ID: 8837658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insect allergy. A comparative study including case histories and immunological parameters.
    Mosbech H
    Allergy; 1984 Oct; 39(7):543-9. PubMed ID: 6496884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic value of the basophil activation test in evaluating Hymenoptera venom sensitization.
    Peternelj A; Silar M; Bajrovic N; Adamic K; Music E; Kosnik M; Korosec P
    Wien Klin Wochenschr; 2009; 121(9-10):344-8. PubMed ID: 19562299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of sIgE/T-IgE in Predicting Systemic Reactions: Retrospective Analysis of 54 Honeybee Venom Allergy Cases in North China.
    Guan K; Li LS; Yin J
    Chin Med J (Engl); 2016 Sep; 129(17):2091-5. PubMed ID: 27569237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Component-resolved diagnosis of wasp (yellow jacket) venom allergy.
    Ebo DG; Faber M; Sabato V; Leysen J; Bridts CH; De Clerck LS
    Clin Exp Allergy; 2013 Feb; 43(2):255-61. PubMed ID: 23331567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural history of Hymenoptera venom allergy in Eastern Spain.
    Fernandez J; Soriano V; Mayorga L; Mayor M
    Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of laboratory testing for the diagnosis of Hymenoptera venom allergy.
    Vachová M; Panzner P; Malkusová I; Hanzlíková J; Vlas T
    Allergy Asthma Proc; 2016 May; 37(3):248-55. PubMed ID: 27178893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-reactive carbohydrate determinants strongly affect the results of the basophil activation test in hymenoptera-venom allergy.
    Mertens M; Amler S; Moerschbacher BM; Brehler R
    Clin Exp Allergy; 2010 Sep; 40(9):1333-45. PubMed ID: 20545702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition.
    Jappe U; Raulf-Heimsoth M; Hoffmann M; Burow G; Hübsch-Müller C; Enk A
    Allergy; 2006 Oct; 61(10):1220-9. PubMed ID: 16942573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
    Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
    Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals.
    Subramaniam S; Aslam A; Misbah SA; Salio M; Cerundolo V; Moody DB; Ogg G
    Eur J Immunol; 2016 Jan; 46(1):242-52. PubMed ID: 26518614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin and radioallergosorbent tests in patients with sensitivity to bee and wasp venom.
    Harries MG; Kemeny DM; Youlten LJ; Mills MM; Lessof MH
    Clin Allergy; 1984 Sep; 14(5):407-12. PubMed ID: 6488511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis of Hymenoptera venom allergy.
    Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity to bee and wasp venoms: association with specific IgE responses to the bee and wasp venom and HLA DRB1 and DPB1.
    Faux JA; Moffatt MF; Lalvani A; Dekker J; Warrell DA; Cookson WO
    Clin Exp Allergy; 1997 May; 27(5):578-83. PubMed ID: 9179434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insect-venom allergy in Greek adults.
    Grigoreas C; Galatas ID; Kiamouris C; Papaioannou D
    Allergy; 1997 Jan; 52(1):51-7. PubMed ID: 9062629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.